Real-world Data on the Efficacy and Safety of Ixazomib-based Therapy in Multiple Myeloma: A Single-center Study in China

OBJECTIVE: To assess the short-term efficacy and safety of ixazomib in Chinese multiple myeloma (MM) patients in the real world. METHODS: Fifty-nine MM patients who received at least one cycle of ixazomib-based therapy between 1 June 2018 and 30 September 2019 were retrospectively analyzed in Tianji...

Descripción completa

Detalles Bibliográficos
Autores principales: Ding, Kai, Yu, Hong, Shao, Yuan-Yuan, Li, Li-Yan, Wang, Chao-Meng, Song, Jia, Li, Li-Juan, Fu, Rong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7520121/
https://www.ncbi.nlm.nih.gov/pubmed/33061589
http://dx.doi.org/10.2147/CMAR.S261887

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7520121/
https://www.ncbi.nlm.nih.gov/pubmed/33061589
http://dx.doi.org/10.2147/CMAR.S261887

Ejemplares similares